SAU · 4018.SR · SAR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 12:15 PM UTC. Cached market data; not a live quote.
One-year closing-price history · SAR. Historical prices are not a forecast.
Almoosa Health Company’s quoted price sits in the lower half of its reported 52-week range, 48.96% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Almoosa Health Company’s forward annual dividend is SAR 1.00 per share, paid quarterly. The forward yield is 0.97% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Almoosa Health Company’s next earnings report is currently expected on Dec 2, 2026, with estimated earnings per share of SAR 0.86. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Almoosa Health Company’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Almoosa Health Company functions as a private healthcare provider situated in Saudi Arabia. The firm engages in storing medical goods and distributing pharmaceuticals, beauty products, and single-use medical supplies. Additionally, it oversees the operation of hospitals and pharmacies, offering a comprehensive suite of services that includes critical care, active rehabilitation, extended care, in-home healthcare assistance, and health-related educational programs. Founded in 1996, the company is headquartered in Al Mubarraz, Saudi Arabia, and operates as a subsidiary of Abdulaziz bin Abdullah Almoosa Investment Company.
Latest available per-share figures in SAR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 02:14 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| SAR 332.11M |
KEEP COMPARING
SAR 221.50-SAR 1.60 (-0.72%)
Dr. Sulaiman Al Habib Medical Services Group Company’s quoted price sits in the lower half of its reported 52-week range, 18.57% below the high.
SAR 55.20-SAR 0.40 (-0.72%)
Mouwasat Medical Services Company’s quoted price sits in the lower half of its reported 52-week range, 29.23% below the high.
SAR 64.95-SAR 0.65 (-0.99%)
Dallah Healthcare Company’s quoted price sits in the lower half of its reported 52-week range, 49.09% below the high.
SAR 30.32-SAR 0.06 (-0.2%)
Dr. Soliman Abdul Kader Fakeeh Hospital Co.’s quoted price sits in the lower half of its reported 52-week range, 29.23% below the high.
SAR 102.10+SAR 3.50 (+3.55%)
National Medical Care Company’s quoted price sits in the lower half of its reported 52-week range, 42.87% below the high.
SAR 21.43-SAR 0.07 (-0.33%)
Al Hammadi Holding Company’s quoted price sits in the lower half of its reported 52-week range, 38.81% below the high.
SAR 12.97+SAR 0.27 (+2.13%)
Specialized Medical Company’s quoted price sits in the lower half of its reported 52-week range, 39.65% below the high.
SAR 23.65-SAR 0.43 (-1.79%)
Middle East Healthcare Company’s quoted price sits in the lower half of its reported 52-week range, 54.08% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
